2015•PubMedRequires access

[Lentiviral vector-mediated Nanog short-hairpin RNA inhibits the growth of human gastric carcinoma xenograft in nude mice].

Kewei Li, Zheng Jiang

Open publisher page 0 citations

Abstract

OBJECTIVE: To construct lentiviral vector that interferes with Nanog, investigate its expression in human gastric cancer cell SGC-7901-transplanted nude mice, and explore the effect of shRNA-Nanog transfection on the growth of the xenograft in mice. METHODS: Lentivirus carrying shRNA-Nanog was prepared by incorporating previously validated siRNA into Nanog gene specific lentiviral vectors. The models of human gastric cancer transplantation were constructed in nude mice. The mouse models were randomly divided into lentivirus-shRNA-Nanog transfection group (experimental group), GFP infection group (empty vector group) and uninfected group (control group). The tumor volume and mass changes were measured. Small animal in vivo imaging was employed to examine the fluorescent intensity and tumor metastasis. The Nanog protein expression was determined by Western blot analysis. The apoptosis of transinfected tumor cells was analyzed by TUNEL method. Results The gene sequencing demonstrated that the recombinant lentivirus carrying shRNA-Nanog was successfully established. In vivo imaging showed that 27 days after transfection, the total fluorescent intensity in the experimental group was significantly lower than that in the empty vector group or the uninfected group. The xenograft volume and mass in the experimental group decreased significantly as compared with those in the empty vector group or the uninfected group. Western blotting indicated that the expression of Nanog protein in the experimental group was significantly lower than that in the empty vector or uninfected group. TUNEL results revealed that the apoptosis rate in the experimental group was significantly higher than that in the other two groups. No statistically significant difference was found between the empty vector group and the uninfected group. CONCLUSION: We successfully established Nanog gene-shRNA expression vector and capsulated it as lentivirus particles, which could inhibit the growth of xenograft in nude mice.

About this research paper

What this paper is about

OBJECTIVE: To construct lentiviral vector that interferes with Nanog, investigate its expression in human gastric cancer cell SGC-7901-transplanted nude mice, and explore the effect of shRNA-Nanog transfection on the growth of the xenograft in mice. METHODS: Lentivirus carrying shRNA-Nanog was prepared by incorporating previously validated siRNA into Nanog gene specific lentiviral vectors. The models of human gastric cancer transplantation were constructed in nude mice. The mouse models were randomly divided into lentivirus-shRNA-Nanog transfection group (experimental group), GFP infection group (empty vector group) and uninfected group (control group). The tumor volume and mass changes were measured. Small animal in vivo imaging was employed to examine the fluorescent intensity and tumor metastasis. The Nanog protein expression was determined by Western blot analysis. The apoptosis of transinfected tumor cells was analyzed by TUNEL method. Results The gene sequencing demonstrated that the recombinant lentivirus carrying shRNA-Nanog was successfully established. In vivo imaging showed that 27 days after transfection, the total fluorescent intensity in the experimental group was significantly lower than that in the empty vector group or the uninfected group. The xenograft volume and mass in the experimental group decreased significantly as compared with those in the empty vector group or the uninfected group. Western blotting indicated that the expression of Nanog protein in the experimental group was significantly lower than that in the empty vector or uninfected group. TUNEL results revealed that the apoptosis rate in the experimental group was significantly higher than that in the other two groups. No statistically significant difference was found between the empty vector group and the uninfected group. CONCLUSION: We successfully established Nanog gene-shRNA expression vector and capsulated it as lentivirus particles, which could inhibit the growth of xenograft in nude mice.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: To construct lentiviral vector that interferes with Nanog, investigate its expression in human gastric cancer cell SGC-7901-transplanted nude mice, and explore the effect of shRNA-Nanog transfection on the growth of the xenograft in mice. METHODS: Lentivirus carrying shRNA-Nanog was prepared by incorporating previously validated siRNA into Nanog gene specific lentiviral vectors. The models of human gastric cancer transplantation were constructed in nude mice. The mouse models were randomly divided into lentivirus-shRNA-Nanog transfection group (experimental group), GFP infection group (empty vector group) and uninfected group (control group). The tumor volume and mass changes were measured. Small animal in vivo imaging was employed to examine the fluorescent intensity and tumor metastasis. The Nanog protein expression was determined by Western blot analysis. The apoptosis of transinfected tumor cells was analyzed by TUNEL method. Results The gene sequencing demonstrated that the recombinant lentivirus carrying shRNA-Nanog was successfully established. In vivo imaging showed that 27 days after transfection, the total fluorescent intensity in the experimental group was significantly lower than that in the empty vector group or the uninfected group. The xenograft volume and mass in the experimental group decreased significantly as compared with those in the empty vector group or the uninfected group. Western blotting indicated that the expression of Nanog protein in the experimental group was significantly lower than that in the empty vector or uninfected group. TUNEL results revealed that the apoptosis rate in the experimental group was significantly higher than that in the other two groups. No statistically significant difference was found between the empty vector group and the uninfected group. CONCLUSION: We successfully established Nanog gene-shRNA expression vector and capsulated it as lentivirus particles, which could inhibit the growth of xenograft in nude mice.

Key concepts: Homeobox protein NANOG, Small hairpin RNA, Transfection, Molecular biology, Viral vector, Apoptosis, Biology, Western blot

Related papers

Back to paper searchBrowse research topicsOriginal source
[Lentiviral vector-mediated Nanog short-hairpin RNA inhibits the growth of human gastric carcinoma xenograft in nude mice]. — Research Paper | ScholarLens